Dr. Ashkan Eliasy
Dr. Ashkan Eliasy

A Framework for Navigating Information Polarization in MedTech Investment

By Dr. Ashkan Eliasy

Information polarization affects public opinion. It can also affect investors. As we approach upcoming elections in different countries, it is crucial to understand how these political events could significantly reshape the landscape for MedTech investments. This article outlines an approach to help investors navigate and understand the interplay of political climates, cultural norms, and healthcare policies without getting emotionally attached to them. It emphasizes the importance of open dialogue, diversity, critical thinking, and cross-cultural collaborations to determine the true potential of MedTech innovations.

Continue reading

Regulations
Regulations

Regulatory Advocacy: Amplifying Your Voice

By MedTech Intelligence Staff

Companies have several avenues available to share their input on and help shape MedTech regulation. At the 2023 MedTech Regulatory Intelligence Summit, former FDA CDRH member Steven Silverman, and Patterson Shafer, strategic advisor to FDA, offered guidance on how to establish credibility with FDA and the most effective ways to make your voice heard.

Continue reading

Alisa Chestler
Alisa Chestler

Overcoming Barriers to EHR Adoption in Behavioral Health

By MedTech Intelligence Staff

Behavioral health providers were excluded from the 2009 HITECH Act, which contributed to significant disparities in EHR adoption between mental and physical health providers. The Behavioral Health Information Technology (BHIT) Coordination Act could help remedy this, yet regulatory and societal barriers to full interoperability remain.

Continue reading